BR112013010774A2 - "usos de crofelemer no tratamento de diarreia associada ao hiv" - Google Patents

"usos de crofelemer no tratamento de diarreia associada ao hiv"

Info

Publication number
BR112013010774A2
BR112013010774A2 BR112013010774A BR112013010774A BR112013010774A2 BR 112013010774 A2 BR112013010774 A2 BR 112013010774A2 BR 112013010774 A BR112013010774 A BR 112013010774A BR 112013010774 A BR112013010774 A BR 112013010774A BR 112013010774 A2 BR112013010774 A2 BR 112013010774A2
Authority
BR
Brazil
Prior art keywords
crofelemer
hiv
treatment
associated diarrhea
diarrhea
Prior art date
Application number
BR112013010774A
Other languages
English (en)
Portuguese (pt)
Inventor
Bortey Enoch
Chaturvedi Pravin
King Steven
Original Assignee
Napo Pharmaceuticals Inc
Salix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013010774(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc, Salix Pharmaceuticals Ltd filed Critical Napo Pharmaceuticals Inc
Publication of BR112013010774A2 publication Critical patent/BR112013010774A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BR112013010774A 2010-10-31 2011-10-31 "usos de crofelemer no tratamento de diarreia associada ao hiv" BR112013010774A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19
PCT/US2011/058549 WO2012058664A1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea

Publications (1)

Publication Number Publication Date
BR112013010774A2 true BR112013010774A2 (pt) 2017-03-21

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013010774A BR112013010774A2 (pt) 2010-10-31 2011-10-31 "usos de crofelemer no tratamento de diarreia associada ao hiv"

Country Status (20)

Country Link
US (4) US8962680B2 (https=)
EP (1) EP2632550B1 (https=)
JP (2) JP6063385B2 (https=)
CN (2) CN107595836A (https=)
AU (1) AU2011320155B2 (https=)
BR (1) BR112013010774A2 (https=)
CA (1) CA2816416C (https=)
DK (1) DK2632550T3 (https=)
EC (1) ECSP13012650A (https=)
ES (1) ES2635435T3 (https=)
HK (1) HK1249036A1 (https=)
HU (1) HUE035393T2 (https=)
MX (1) MX348184B (https=)
PE (1) PE20140036A1 (https=)
PH (1) PH12013500857A1 (https=)
PL (1) PL2632550T3 (https=)
PT (1) PT2632550T (https=)
RU (1) RU2597746C2 (https=)
WO (1) WO2012058664A1 (https=)
ZA (1) ZA201303136B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2241318T1 (sl) 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
ES2616012T3 (es) 2006-05-01 2017-06-09 Napo Pharmaceuticals, Inc. Composiciones para tratar o prevenir enfermedad inflamatoria del intestino
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
CN107595836A (zh) 2010-10-31 2018-01-19 纳珀制药公司 用于治疗hiv相关性腹泻的方法和组合物
EP2928560A4 (en) * 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JP7328153B2 (ja) 2017-05-31 2023-08-16 ナポ ファーマシューティカルズ インク． 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物
US11857510B2 (en) 2017-05-31 2024-01-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating congenital diarrhea disorder
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
CA3182864A1 (en) * 2020-06-19 2021-12-23 Lisa A. CONTE Methods and compositions for treating chemotherapy-induced diarrhea
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
EP2060183A3 (en) 1996-10-16 2009-06-03 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2008546790A (ja) * 2005-06-22 2008-12-25 ユニバーシティー オブ マサチューセッツ Ｈｉｖ−１プロテアーゼ阻害剤
CA2633417A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
SI2241318T1 (sl) * 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
ES2616012T3 (es) 2006-05-01 2017-06-09 Napo Pharmaceuticals, Inc. Composiciones para tratar o prevenir enfermedad inflamatoria del intestino
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
WO2011024049A2 (en) 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
AU2010303577B2 (en) 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
CN107595836A (zh) 2010-10-31 2018-01-19 纳珀制药公司 用于治疗hiv相关性腹泻的方法和组合物
WO2012101008A1 (en) 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
BR112014015314A2 (pt) 2011-12-22 2017-06-13 Glenmark Pharmaceuticals Ltd composição farmacêutica não entérica compreendendo crofelemer
EP2928560A4 (en) 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA

Also Published As

Publication number Publication date
US8962680B2 (en) 2015-02-24
EP2632550B1 (en) 2017-05-03
CN103370101A (zh) 2013-10-23
PE20140036A1 (es) 2014-01-31
RU2013123794A (ru) 2014-12-10
WO2012058664A1 (en) 2012-05-03
MX2013004873A (es) 2013-08-21
US20120107370A1 (en) 2012-05-03
MX348184B (es) 2017-06-02
HUE035393T2 (en) 2018-05-02
ES2635435T3 (es) 2017-10-03
DK2632550T3 (en) 2017-08-07
AU2011320155B2 (en) 2016-02-25
CA2816416A1 (en) 2012-05-03
CA2816416C (en) 2020-02-11
US20140294903A1 (en) 2014-10-02
US9585868B2 (en) 2017-03-07
EP2632550A4 (en) 2014-04-23
US20120184605A1 (en) 2012-07-19
ECSP13012650A (es) 2013-10-31
EP2632550A1 (en) 2013-09-04
PH12013500857A1 (en) 2018-01-17
PL2632550T3 (pl) 2017-10-31
JP2017019806A (ja) 2017-01-26
JP6310971B2 (ja) 2018-04-11
JP2013540826A (ja) 2013-11-07
ZA201303136B (en) 2016-01-27
AU2011320155A1 (en) 2013-05-09
HK1249036A1 (zh) 2018-10-26
JP6063385B2 (ja) 2017-01-18
US20150190367A1 (en) 2015-07-09
RU2597746C2 (ru) 2016-09-20
CN107595836A (zh) 2018-01-19
PT2632550T (pt) 2017-08-02

Similar Documents

Publication Publication Date Title
BR112013010774A2 (pt) "usos de crofelemer no tratamento de diarreia associada ao hiv"
HUS2400017I1 (hu) Dolutegravir és lamivudin kombinációi HIV-fertõzés kezelésére
IL308158A (en) Rna-guided human genome engineering
IL253225B (en) Sulfamoyl-arylamides and their use as drugs to treat jaundice b
GB2478595B (en) Phytocannabinoids in the treatment of glioma
CL2014002631A1 (es) Anticuerpos anti - hla - b*27 y usos de estos
SI2935303T1 (sl) 4'-fluoro-nukleozidi, 4'-fluoro-nukleotidi in njihovi analogi za zdravljenje HCV
IT1402907B1 (it) Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.
PL2448734T3 (pl) Preforma, pojemnik i sposób formowania pojemnika
EP2934378A4 (en) CATHETER ORIENTATION MARKER
BR112014030953A2 (pt) "dispositivo de diagnóstico in vitro e usos"
EP2878627A4 (en) THERMOPLASTIC RESIN COMPOSITION AND FILM THEREWITH
EP2640257A4 (en) EFFECTIVE SHIELDING AND REFRACTION TARGETS
EP2650328A4 (en) MODIFIED POLYPROPYLENE COMPOSITION AND LAMINATE THEREWITH
LT2872145T (lt) Sujungti benzazepinai tureto sindromui gydyti
EP2876088A4 (en) WATER CLEANER
EP2855363A4 (en) WATER TREATMENT
BR112013007039A2 (pt) "composição de tratamento pessoal"
LT2531124T (lt) Prietaisai odos pažeidimams gydyti
ZA201202797B (en) The use of a herbal composition for the treatment of a person infected with hiv
BR112012022620A2 (pt) "equipamento para tratamento de recipientes de produto quimíco"
HRP20151393T8 (hr) UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
ZA201405910B (en) Use of modafinil in the treatment of cocaine addicts
PT2637974T (pt) Composição multifuncional para o tratamento de desinfecção da água e utilização desta composição
BR112012025829A2 (pt) ''composição de tratamento, composição líquido e utilização''

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25G Requested change of headquarter approved

Owner name: SALIX PHARMACEUTICALS, LTD. (US) , NAPO PHARMACEUT

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: NAPO PHARMACEUTICALS, INC. (US) , SALIX PHARMACEUTICALS, INC. (US)

Owner name: NAPO PHARMACEUTICALS, INC. (US) , SALIX PHARMACEUT

B25A Requested transfer of rights approved

Owner name: NAPO PHARMACEUTICALS, INC. (US)

B25G Requested change of headquarter approved

Owner name: NAPO PHARMACEUTICALS, INC. (US)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]